Restless Legs Syndrome and Obesity
Restless legs syndrome is an urge to move the legs that is worse at rest and in the evening; obesity and a larger waist are associated with a higher risk, and the two conditions share altered dopamine signalling and iron handling.
Plain English
Patient-Friendly Explanation
Restless legs syndrome is a condition in which an unpleasant urge to move the legs appears when a person is sitting or lying still, particularly in the evening and at night, and is relieved for a while by movement. It makes it hard to fall asleep and is a recognised cause of chronic insomnia, daytime tiredness and low mood. Obesity is a risk factor. In two large United States cohorts, 6.4 per cent of women and 4.1 per cent of men met the diagnostic criteria, and the likelihood rose steadily with body mass index: people with a body mass index of 30 or more were roughly 40 to 60 per cent more likely to have restless legs than those with a body mass index below 23. Waist circumference mattered as much as weight, with those in the top fifth of waist measurement about 60 per cent more likely to be affected, and weight gain in adult life was also associated with a higher risk. A later prospective study that followed more than fifty thousand people who did not have the condition at the start found that obesity predicted developing it, which supports the idea that excess weight contributes to the cause rather than simply accompanying it. A pooled analysis of fifteen studies covering nearly two hundred thousand people found a clear positive association, with the link appearing stronger in women. The likely explanation involves two things that obesity and restless legs share. The first is dopamine signalling: people with a higher body mass index have fewer available dopamine D2 receptors in the brain, and dopamine is central to the control of movement and to this condition. The second is iron, because iron is needed to make dopamine and iron deficiency is common in obesity and after weight-loss surgery. Treatment begins with correcting iron deficiency, reviewing medicines that worsen the symptoms, and treating any sleep apnoea; weight reduction and regular activity may also help, although the evidence that weight loss resolves the condition is limited.
Medical
Clinical Definition
Restless legs syndrome (RLS) is diagnosed clinically by an urge to move the legs with unpleasant sensations that begin or worsen at rest, follow a circadian pattern with evening and night worsening, are relieved by movement, and cause distress or sleep disturbance. In the Nurses Health Study II and the Health Professionals Follow-up Study, 6.4% of women and 4.1% of men met International RLS Study Group criteria, and the pooled multivariable-adjusted odds ratio for RLS was 1.42 (95% CI 1.3 to 1.6) for a body mass index of 30 or more compared with less than 23, 1.60 (95% CI 1.5 to 1.8) for the top versus the bottom quintile of waist circumference, and 1.41 (95% CI 1.3 to 1.6) for the top versus the bottom quintile of adult weight gain. A prospective analysis of 42,728 women and 12,812 men who were free of RLS at baseline found that obesity predicted incident RLS, with a pooled adjusted odds ratio of 1.57 (95% CI 1.33 to 1.85) for a body mass index above 30 versus 23 or below and 1.56 (95% CI 1.29 to 1.89) when extreme waist circumference quintiles were compared; raised total cholesterol was also associated (odds ratio 1.33) whereas hypertension was not. A systematic review and meta-analysis of 15 studies including 197,204 participants found a positive association overall, with a five-fold increase in case-control studies and increases of 59% in cohort and 36% in cross-sectional studies, the association being stronger in women. Mechanisms proposed include reduced central dopamine D2 receptor availability with increasing adiposity, and altered iron handling, because iron is a cofactor for tyrosine hydroxylase and obesity is associated with lower iron availability and higher hepcidin. Secondary causes must be excluded, particularly iron deficiency, pregnancy, renal failure, peripheral neuropathy and the use of antidepressants or antihistamines, and RLS is strongly associated with obstructive sleep apnoea. Management begins with serum ferritin and transferrin saturation, treatment of iron deficiency, review of aggravating drugs and treatment of sleep apnoea; dopamine agonists and gabapentinoids are used for refractory symptoms but carry augmentation and impulse-control risks. Weight reduction and physical activity are reasonable adjuncts with limited direct trial evidence.
Key Insight
Why It Matters
Restless legs syndrome matters in a weight clinic because it is common, it is a frequent and treatable cause of poor sleep, and it is one of the conditions that ties obesity to altered dopamine signalling and iron handling. Sleep loss in turn worsens appetite regulation and weight gain, so the two problems reinforce each other. Patients should be asked about these symptoms when they report poor sleep, and the workup should include ferritin, a review of aggravating medicines and an assessment for sleep apnoea, with weight reduction as a supporting measure rather than a stand-alone treatment.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: October 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
